Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry

INTRODUCTION: Scientific evidence of the effectiveness of the tumor necrosis factor inhibitor adalimumab (ADA) in pediatric patients with non-infectious non-anterior uveitis is still limited. The aim of this study is to investigate the therapeutic role of ADA in a cohort of pediatric patients with n...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Antonio, Casa, Francesca Della, Guerriero, Silvana, Ragab, Gaafar, Mauro, Angela, Caggiano, Valeria, Cattalini, Marco, Del Giudice, Emanuela, Favale, Rossella, Gaggiano, Carla, Bellicini, Irene, Paroli, Maria Pia, Hegazy, Mohamed Tharwat, Sota, Jurgen, Tufan, Abdurrahman, Balistreri, Alberto, Almaghlouth, Ibrahim, La Torre, Francesco, Więsik-Szewczyk, Ewa, Tarsia, Maria, Hinojosa-Azaola, Andrea, Martín-Nares, Eduardo, Frediani, Bruno, Tosi, Gian Marco, Fonollosa, Alex, Hernández-Rodríguez, José, Amin, Rana Hussein, Lopalco, Giuseppe, Rigante, Donato, Cantarini, Luca, Fabiani, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287589/
https://www.ncbi.nlm.nih.gov/pubmed/37166627
http://dx.doi.org/10.1007/s40123-023-00712-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287589/
https://www.ncbi.nlm.nih.gov/pubmed/37166627
http://dx.doi.org/10.1007/s40123-023-00712-1

Ejemplares similares